Table 2.
IL-12:IL-10 ratio | ||||
---|---|---|---|---|
Lactoferrin (μg/mL) | – | 1 | 10 | 100 |
LPS (ng/mL) | 1 | 1 | 1 | 1 |
Average ratio | 18.64 | 15.04 | 10.25* | 28.88* |
Standard deviation | 0.47 | 1.20 | 0.21 | 1.46 |
Lactoferrin (μg/mL) | – | 1 | 10 | 100 |
LPS (ng/mL) | 10 | 10 | 10 | 10 |
Average ratio | 19.80 | 19.99 | 21.57 | 30.27+ |
Standard deviation | 0.01 | 0.01 | 0.01 | 0.01 |
Lactoferrin (μg/mL) | – | 1 | 10 | 100 |
BCG (MOI) | 10:1 | 10:1 | 10:1 | 10:1 |
Average ratio | 6.57 | 8.81* | 16.56* | 11.65* |
Standard deviation | 0.51 | 0.42 | 1.02 | 0.72 |
J774A.1 macrophages were stimulated with 1 ng/mL LPS (top) or 10 ng/mL LPS (middle) with or without increasing concentrations of Lactoferrin (1, 10, 100 μg/mL). Alternatively, cells were infected with BCG (MOI 10:1) (bottom) with or without Lactoferrin. Supernatants were collected at 72 h and analyzed by ELISA. Ratio was calculated by dividing concentration of IL-12p40 by IL-10.
P < 0.05 relative to non-Lactoferrin treated controls